In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms
Clinical trial NCT07586709 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07586709
- Sponsor
- Liping Dou
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-09
- Primary completion
- 2029-03-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.